Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1)

This is a pilot study looking at the effect of Gabapentin in women with chronic pelvic pain. Participants were assigned at random to the placebo or the drug group. The design follows procedure of double blinding, i.e. neither patients, nor people involved in data collection or analysis knew the participants group. There was two sessions on thermal stimulation, in which a thermal probe was applied to the abdomen or to the hand. After each stimulation are two rating scales were presentated in succession. In a third session, punctuations were applied to he hand and fMRI scans conducted. The full study (not fMRI) report has been published here: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153037 .

Horne, Andrew; Vincent, Katy; Pernet, Cyril. (2018). Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1), [dataset]. University of Edinburgh. College of Medicine & Veterinary Medicine. Clinical Sciences. Edinburgh Imaging. http://dx.doi.org/10.7488/ds/2411.